149 related articles for article (PubMed ID: 6316331)
1. Monoclonal antibodies that prevent adhesion of B 16 melanoma cells and reduce metastases in mice: crossreaction with human tumor cells.
Vollmers HP; Birchmeier W
Proc Natl Acad Sci U S A; 1983 Nov; 80(22):6863-7. PubMed ID: 6316331
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies inhibit the adhesion of mouse B 16 melanoma cells in vitro and block lung metastasis in vivo.
Vollmers HP; Birchmeier W
Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3729-33. PubMed ID: 6574511
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies NORM-1 and NORM-2 induce more normal behavior of tumor cells in vitro and reduce tumor growth in vivo.
Vollmers HP; Imhof BA; Wieland I; Hiesel A; Birchmeier W
Cell; 1985 Mar; 40(3):547-57. PubMed ID: 2982498
[TBL] [Abstract][Full Text] [Related]
4. Differentiation antigens of mouse teratocarcinoma stem cells defined by monoclonal antibodies.
Dráber P; Pokorná Z
Cell Differ; 1984 Dec; 15(2-4):109-13. PubMed ID: 6535637
[TBL] [Abstract][Full Text] [Related]
5. Syngeneic monoclonal antibodies to B16 melanoma viral antigens.
Rappaport I; Alterman AL; Braverman S; Stackpole CW
Cancer Res; 1987 Oct; 47(20):5391-6. PubMed ID: 3652042
[TBL] [Abstract][Full Text] [Related]
6. Surface antigens common to mouse cleavage embryos and primitive teratocarcinoma cells in culture.
Artzt K; Dubois P; Bennett D; Condamine H; Babinet C; Jacob F
Proc Natl Acad Sci U S A; 1973 Oct; 70(10):2988-92. PubMed ID: 4355379
[TBL] [Abstract][Full Text] [Related]
7. The expression of tumor-associated antigens in primary and metastatic human malignant melanoma.
Brüggen J; Bröcker EB; Suter L; Redmann K; Sorg C
Behring Inst Mitt; 1984 May; (74):19-23. PubMed ID: 6477352
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody recognizing human melanoma-carcinoma cross-reacting oncofetal antigen epitopically associated with carcinoembryonic antigen.
Liao SK; Kwong PC; Clarke BJ; Dent PB; Ryan ED; Khosravi MJ; Laferte S; Krantz MJ
J Natl Cancer Inst; 1985 May; 74(5):1047-58. PubMed ID: 2582173
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies that demonstrate specificity for several types of human lung cancer.
Cuttitta F; Rosen S; Gazdar AF; Minna JD
Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4591-5. PubMed ID: 6270685
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies which prevent experimental lung metastases. Interference with the adhesion of tumour cells to laminin.
Vollmers HP; Imhof BA; Braun S; Waller CA; Schirrmacher V; Birchmeier W
FEBS Lett; 1984 Jun; 172(1):17-20. PubMed ID: 6734821
[TBL] [Abstract][Full Text] [Related]
11. Antisperm antibodies in mouse vasectomy sera react with embryonal teratocarcinoma.
Anderson DJ; Adams PH; Hamilton MS; Alexander NJ
J Immunol; 1983 Dec; 131(6):2908-12. PubMed ID: 6644023
[TBL] [Abstract][Full Text] [Related]
12. Tissue specificity of anti melanoma monoclonal antibodies analyzed on cell lines.
Johnson JP; Riethmüller G
Hybridoma; 1982; 1(4):381-5. PubMed ID: 6208134
[TBL] [Abstract][Full Text] [Related]
13. Mouse monoclonal antibody (FKH1) detecting human melanoma-associated antigens.
Fukaya T; Hashimoto K; Eto H; Mehregan A
Cancer Res; 1986 Oct; 46(10):5195-200. PubMed ID: 3756874
[TBL] [Abstract][Full Text] [Related]
14. Detection of phenotypic differences on human malignant melanoma lines and their variant sublines with monoclonal antibodies.
Brüggen J; Sorg C
Cancer Immunol Immunother; 1983; 15(3):200-5. PubMed ID: 6555061
[TBL] [Abstract][Full Text] [Related]
15. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
16. Syngeneic monoclonal antibodies against melanoma antigens with species specificity and interspecies cross-reactivity.
Wakabayashi S; Saito T; Shinohara N; Okamoto S; Tomioka H; Taniguchi M
J Invest Dermatol; 1984 Aug; 83(2):128-33. PubMed ID: 6206164
[TBL] [Abstract][Full Text] [Related]
17. Establishment of paired tumor cells and autologous virus-transformed cell lines to define humoral immune responses in melanoma and sarcoma patients.
Saxton RE; Irie RF; Ferrone S; Pellegrino MA; Morton DL
Int J Cancer; 1978 Mar; 21(3):299-306. PubMed ID: 204583
[TBL] [Abstract][Full Text] [Related]
18. Fluctuations in the expression of a glycolipid antigen associated with differentiation of melanoma cells monitored by a monoclonal antibody, Leo Mel 3.
Werkmeister JA; Triglia T; Mackay IR; Dowling JP; Varigos GA; Morstyn G; Burns GF
Cancer Res; 1987 Jan; 47(1):225-30. PubMed ID: 3791209
[TBL] [Abstract][Full Text] [Related]
19. Murine melanoma-specific tumor rejection activity elicited by a purified, melanoma-associated antigen.
Hearing VJ; Gersten DM; Montague PM; Vieira WD; Galetto G; Law LW
J Immunol; 1986 Jul; 137(1):379-84. PubMed ID: 3711669
[TBL] [Abstract][Full Text] [Related]
20. Mouse monoclonal antibody to a melanoma-carcinoma-associated antigen synthesized by a human melanoma cell line propagated in serum-free medium.
Chee DO; Yonemoto RH; Leong SP; Richards GF; Smith VR; Klotz JL; Goto RM; Gascon RL; Drushella MM
Cancer Res; 1982 Aug; 42(8):3142-7. PubMed ID: 7046918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
